HighField Biopharmaceuticals’ new immuno-oncology drug molecule HF1K16 shows safe and signals efficacy in treating refractory metastatic cancers: Hanghou, China Wednesday, Septe ...

Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization of mirvetuximab soravtansine (ELAHERE®) for the ...

Intravenous RNAi gene therapy using Trojan horse liposomes has ... Glutathione PEGylated liposomal doxorubicin (2B3–101) is in Phase I/II clinical trials in patients with brain cancer.

Penn gene therapy pioneer Dr. Jim Wilson said his decision to leave academia to become full-time CEO of two startups he ...

Scientists at Trinity College Dublin have developed a promising gene therapy for glaucoma, shown to protect retinal cells and ...

Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

Nationwide Children's Hospital has renamed its gene therapy research program and clinics for Dr. Jerry Mendell, who devoted ...

Sep. 9, 2024 — Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million ...

Advancements in cell and gene therapy have been driven by improved insights into the human immune system and a better ...

Gene therapies are raising hopes for patients with rare disorders, various cancers, and complex neurological diseases. But there are ethical and policy challenges on the path from research to the ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.